PROspective Master-protocol for Evaluation of Systemic THErapeutics in Elderly With Thoracic Malignancies
- Conditions
- Non Small Cell Lung CancerLung Cancer
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 500
- Registration Number
- NCT06646471
- Locations
- 🇫🇷
CH du Pays d Aix, Aix En Provence, France
🇫🇷Hôpital Henri Duffaut, Avignon, France
🇫🇷CH Bastia, Bastia, France
Trial for Local Ablative Treatment (LAT) Optimization in Patients With Advanced Non-Small Cells Lung Cancer (NSCLC) Presenting an Anaplastic Lymphoma Kinase (ALK) Rearrangement Treated by Brigatinib
- Conditions
- NSCLC
- Interventions
- Biological: Blood samples for HematologyBiological: Blood samples for ChemistryBiological: Blood sample for liver function testsBiological: Pregnancy testProcedure: Tumour assessmentProcedure: Local Ablative Therapy (LAT)
- First Posted Date
- 2024-10-01
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 45
- Registration Number
- NCT06620835
- Locations
- 🇫🇷
CHU de Brest, Brest, France
🇫🇷Centre François Baclesse, Caen, France
🇫🇷CH Métropole-Savoie, Chambery, France
Mechanisms of Resistance to Amivantamab in Patients With NSCLC With EGFR Exon 20 Insertion
- Conditions
- Non-small Cell Lung CancerEGFR Exon 20 Insertion Mutation
- Interventions
- Procedure: Blood sampling
- First Posted Date
- 2024-02-08
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 30
- Registration Number
- NCT06247826
- Locations
- 🇫🇷
Oncologie Polyclinique Bordeaux Nord Aquitaine, Bordeaux, France
🇫🇷Centre Hospitalier du Morvan, Brest, France
🇫🇷Pneumologie Centre Hospitalier Intercommunal de Créteil, Creteil, France
Observational Study in Patients With Previously Unresectable Malignant Pleural Mesothelioma Treated With Nivolumab and Ipilimumab (MESO-IMMUNE)
- Conditions
- Malignant Pleural MesotheliomaUnresectable Malignant Neoplasm
- Interventions
- Other: Data collection
- First Posted Date
- 2022-04-04
- Last Posted Date
- 2023-10-23
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 200
- Registration Number
- NCT05308966
- Locations
- 🇫🇷
CHU du Pays d'Aix, Aix-en-Provence, France
🇫🇷CH Albi, Albi, France
🇫🇷CHU Angers, Angers, France
Analysis of Biological Characteristics of Advanced ALK-rearranged NSCLC
- Conditions
- Non-small Cell Lung CancerALK Gene Rearrangement Positive
- Interventions
- Genetic: RNAseq
- First Posted Date
- 2021-11-17
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 100
- Registration Number
- NCT05122806
- Locations
- 🇫🇷
Pneumologie CHU Félix Guyon, Saint-Denis, La Réunion, France
🇫🇷Centre Hospitalier d'Aix en Provence, Aix En Provence, France
🇫🇷Pneumologie CHU, Amiens, France
Observational Prospective Study of Quality of Life in Unresectable TNM Stage III NSCLC (OBSTINATE)
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- Other: Quality of Life Questionnaire-Core 30 (QLQ-C30)
- First Posted Date
- 2021-09-17
- Last Posted Date
- 2023-10-19
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 413
- Registration Number
- NCT05049044
- Locations
- 🇫🇷
Centre Hospitalier d'Aix en Provence, Aix En Provence, France
🇫🇷CHU Amiens-Picardie, Amiens, France
🇫🇷Centre Hospitalier Universitaire, Angers, France
Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)
- Conditions
- Large Cell Lung CancerNeuroendocrine Carcinoma of Lung (Diagnosis)
- First Posted Date
- 2017-10-09
- Last Posted Date
- 2020-03-12
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 86
- Registration Number
- NCT03305133
- Locations
- 🇫🇷
Centre Hospitalier D Argenteuil, Argenteuil, VAL D'oise, France
🇫🇷Site 12, Aix En Provence, France
🇫🇷Centre Hospitalier Universitaire, Angers, France
Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.
- Conditions
- Lung Cancer
- Interventions
- Other: Assessment of PDL1 expression
- First Posted Date
- 2016-05-30
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 170
- Registration Number
- NCT02785562
- Locations
- 🇫🇷
Centre Hospitalier D Argenteuil, Argenteuil, VAL D'oise, France
🇫🇷Site 12, Aix En Provence, France
🇫🇷Centre Hospitalier Universitaire, Angers, France
Retrospective Study in Non Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR)
- Conditions
- NSCLC Non Small Cells Lung Cancer
- First Posted Date
- 2014-11-18
- Last Posted Date
- 2014-11-18
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 144
- Registration Number
- NCT02293733
- Locations
- 🇫🇷
Centre Hospitalier D Argenteuil, Argenteuil, Val D'oise, France
🇫🇷Site 12, Aix En Provence, France
🇫🇷Centre Hospitalier Universitaire, Angers, France
Feasibility of re Biopsies at Progression
- Conditions
- Lung Cancer
- Interventions
- Procedure: re biopsy
- First Posted Date
- 2014-03-13
- Last Posted Date
- 2020-03-13
- Lead Sponsor
- Groupe Francais De Pneumo-Cancerologie
- Target Recruit Count
- 100
- Registration Number
- NCT02086071
- Locations
- 🇫🇷
Centre Hospitalier Universitaire, Angers, France
🇫🇷Centre Hospitalier du Morvan, Brest, France
🇫🇷Centre François Baclesse, Caen, France